SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-063212
Filing Date
2023-08-04
Accepted
2023-08-04 08:30:02
Documents
2
Period of Report
2023-08-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea182848-6k_universephar.htm 6-K 9237
2 PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC ANNOUNCES RECEIPT OF NASDAQ NOTIFIC ea182848ex99-1_universephar.htm EX-99.1 9440
  Complete submission text file 0001213900-23-063212.txt   19772
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 231142283
SIC: 2834 Pharmaceutical Preparations